Showing 1121-1130 of 4012 results for "".
MIRASOL Insights in PROC: A Biomarker-Driven Approach
https://reachmd.com/programs/project-oncology/mirasol-proc-biomarker-approach/37252/In platinum-resistant ovarian cancer (PROC), survival is usually measured in months,1-3 and most patients will have already received multiple prior lines of therapy.4 Biomarker-driven therapy has helped change the treatment landscape.5-10 Tune in to learn more about mirvetuximab soravtansine-gynx asGaps in Shingles Vaccination: What Clinicians Need to Know
https://reachmd.com/programs/vaccination/gaps-shingles-vaccination/54087/While shingles poses a significant but preventable threat for older and immunocompromised adults, vaccination rates remain critically low. To help address this concerning gap in care, this brief video explores how we can identify eligible patients, confidently recommend vaccination, and incorporateZika Virus Update: Answers from a Maternal‐Fetal Medicine Specialist
https://reachmd.com/programs/clinicians-roundtable/zika-virus-update-answers-from-maternal-fetal-medicine-specialist/8428/Dr. Martin Chavez describes the effects of the Zika virus outbreak on maternal and fetal health.Patient Barriers to Accessing IUDs and Implants in Today's Contraceptive Market
https://reachmd.com/programs/clinicians-roundtable/patient-barriers-accessing-iuds-and-implants-todays-contraceptive-market/8300/Dr. Anita Nelson discusses patient barriers to accessing IUDs and implants in a rapidly growing contraceptive market.2020 AHA/ACC Guideline Updates: Hypertrophic Cardiomyopathy
https://reachmd.com/programs/advanced-treatments-innovations-mayo-clinic/2020-aha-acc-guideline-updates-hypertrophic-cardiomyopathy/12144/Hypertrophic cardiomyopathy is a disease that often goes underdiagnosed. How can physicians better detect and treat this potentially fatal disease?The Power of Digital Marketing in Today’s Aesthetic Space
https://reachmd.com/topics/practice-development/the-power-of-digital-marketing-in-todays-aesthetic-space-1/35192/Monitoring Disease Course and Treatment Response in Various Populations With Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/monitoring-disease-course-and-treatment-response-in-various-populations-with-multiple-sclerosis/33144/Monitoring for signs of disease activity or progression in multiple sclerosis—a crucial component of disease management—may need refinement for pediatric, pregnant or postpartum, older, and minority or underserved populations.Targeting CKD-aP at the Source: Key Mechanisms and Treatments
https://reachmd.com/programs/cme/targeting-ckd-ap-at-the-source-key-mechanisms-and-treatments/37606/Explore CKD-associated pruritus mechanisms, clinical impact, and evidence-based treatments, including kappa-opioid receptor agonists.Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
https://reachmd.com/programs/cme/case-based-approach-managing-hyperkalemia-in-patients-with-ckd-and-heart-failure/37617/Explore expert tips on using potassium binders to manage hyperkalemia and maintain GDMT in patients with CKD and heart failure.Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
https://reachmd.com/programs/cme/stuck-on-antihistamines-for-managing-patients-with-ckd-ap-time-to-reconsider/37607/Apply clinical practice guideline recommendations in managing patients with chronic kidney disease-associated pruritus (CKD-aP).